Seminars in Nuclear Medicine
Volume 38, Issue 5 , Pages 347-357, September 2008

Risks to Normal Tissues From Radionuclide Therapy

  • Ruby Meredith, MD, PhD

      Affiliations

    • University of Alabama at Birmingham, Birmingham, AL.
    • Corresponding Author InformationAddress reprint requests to Ruby Meredith, MD, PhD, Department of Radiation Oncology, University of Alabama at Birmingham, 1824 6th Ave South, Birmingham, AL 35249.
    • ,
  • Barry Wessels, PhD

      Affiliations

    • Case Western Reserve University, Cleveland, OH.
    • ,
  • Susan Knox, MD, PhD

      Affiliations

    • Stanford University, Stanford, CA.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Support for some clinical trials was from NIH M01 RR-00032.

PII: S0001-2998(08)00068-8

doi:10.1053/j.semnuclmed.2008.05.001

Seminars in Nuclear Medicine
Volume 38, Issue 5 , Pages 347-357, September 2008

Article Tools